HEALTH● LOWJul 30 · Jul 30, 2026, 5:26 PM
BMS granted FDA review for label expansion of Merck-partnered anemia therapy
Seeking Alpha Tech
BMS has received FDA review approval for expanding the label of its anemia therapy, developed in partnership with Merck. This marks a regulatory step forward for the pharmaceutical product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoEbola: NCDC tracks 53 contacts, orders hospitals to isolate suspectsVanguard NigeriaHEALTH1h agoNCDC approves N100,000 weekly stipend for Ebola contactsVanguard NigeriaHEALTH1h agoEbola: 53 Contacts, Including Healthcare Workers Under Surveillance, Says NCDCChannels TVHEALTH1h agoAstraZeneca stomach cancer drug doubles survival in late-stage trialSeeking Alpha Tech